New EU regulation on health technology assessment of cancer medicines

Lancet Oncol. 2022 Feb;23(2):e58. doi: 10.1016/S1470-2045(22)00008-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents*
  • Drug and Narcotic Control*
  • European Union
  • Humans
  • Technology Assessment, Biomedical / legislation & jurisprudence*

Substances

  • Antineoplastic Agents